移植前及纵向粪便微生物组特征变化与后续慢性移植物抗宿主病发生相关
本研究分析11例后续发生慢性移植物抗宿主病(cGVHD)患者与13例未发生急性或慢性GVHD对照的移植前粪便样本及移植后纵向变化,发现两组基线多个菌群丰度存在显著差异,cGVHD组植入后α多样性下降更明显,且cGVHD组微生物组富集短链脂肪酸代谢相关通路,而对照组富集色氨酸分解代谢通路。
要点
- cGVHD组与对照组移植前粪便微生物组多个菌群丰度存在显著差异,包括放线菌门和梭菌属。
- 纵向分析显示cGVHD组从基线至植入后α多样性下降幅度大于对照组。
- cGVHD组微生物组富集β-氧化和酰基辅酶A合成及γ-氨基丁酸旁路两条短链脂肪酸代谢通路,对照组富集色氨酸分解代谢通路。
核心结论
- 研究显示cGVHD发生前存在独特的基线微生物组及代谢能力模式,可能参与调节异体反应性。
- 作者认为这些发现支持通过微生物组干预预防cGVHD的治疗潜力。
研究设计与样本
- 分析11例后续发生cGVHD患者与13例未发生急性GVHD或cGVHD对照的移植前基线粪便样本。
- 对每例患者纵向样本进行亚组分析,比较基线至植入后微生物组变化。
- 进行微生物组组成及代谢通路分析。
主要发现
- cGVHD组与对照组基线多个菌群丰度存在显著差异,包括放线菌门和梭菌属。
- cGVHD组从基线至植入后α多样性下降幅度大于对照组。
- cGVHD组微生物组富集β-氧化和酰基辅酶A合成及γ-氨基丁酸旁路两条短链脂肪酸代谢通路。
- 对照组富集色氨酸分解代谢通路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The role of the gastrointestinal microbiome in predisposing to chronic graft-versus-host disease (cGVHD), an immune-mediated haematopoietic cell transplant (HCT) complication, is not well defined. We examined the relationship of the host faecal microbiome with subsequent cGVHD development by analysing baseline stool samples as well as post-HCT changes in microbiome composition and metabolite pathway analyses. We analysed pre-transplant baseline samples from 11 patients who subsequently developed cGVHD compared to 13 controls who did not develop acute GVHD or cGVHD at any time. We found a significant differential abundance of multiple taxa at baseline between cGVHD versus controls, including the Actinobacteria phylum and Clostridium genus. A subgroup analysis of longitudinal samples within each patient revealed a greater loss of alpha diversity from baseline to post-engraftment in patients who subsequently developed cGVHD. Metabolic pathways analysis revealed that two pathways associated with short-chain fatty acid metabolism were enriched in cGVHD patient microbiomes: β-oxidation and acyl-CoA synthesis, and γ-aminobutyrate shunt. In contrast, a tryptophan catabolism pathway was enriched in controls. Our findings show a distinct pattern of baseline microbiome and metabolic capacity that may play a role in modulating alloreactivity in patients developing cGVHD. These findings support the therapeutic potential of microbiome manipulation for cGVHD prevention.
引用
- El Jurdi N, Holtan SG, Hoeschen A, et al. Pre-transplant and longitudinal changes in faecal microbiome characteristics are associated with subsequent development of chronic graft-versus-host disease. Br J Haematol. 2023. PMID: 37553783. doi:10.1111/bjh.19016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。